Q: No questions in the database.
Winner on COVID vaccine fight as they supply the material needed for test kits,. etc. Stock up a lot this year but seems to have started gaining traction with new CEO ~5 years ago - and started international growth.
Balance sheet in good shape and increasing ROE. Expensive.
What do you think longer term?
Winner on COVID vaccine fight as they supply the material needed for test kits,. etc. Stock up a lot this year but seems to have started gaining traction with new CEO ~5 years ago - and started international growth.
Balance sheet in good shape and increasing ROE. Expensive.
What do you think longer term?